About
OpZira, Inc. is a forward-thinking ophthalmic medical device company founded on a legacy of research excellence. We deliver innovative technologies designed to enhance the detection and monitoring of ocular disease. AdaptDx Pro® is a wearable dark adaptometer leveraging AI to ensure a consistent patient experience. Impaired dark adaptation speed – a key early indicator of rod-mediated dysfunction – is often one of the first functional signs of retinal disease. AdaptDx Pro is available in the U.S. EVERGE™ Vision Testing System is a robust electrophysiology platform that provides objective assessments of the entire visual and neuro-visual pathway. VEP is available in the U.S. and select international markets. ERG is only available outside of the U.S. For more information, visit OpZira.com.
Technologies
Keywords
Company Information
-
Employees 13
